Lawrence R. McGee

2.5k total citations
28 papers, 1.3k citations indexed

About

Lawrence R. McGee is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Lawrence R. McGee has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in Lawrence R. McGee's work include Chemical Synthesis and Analysis (4 papers), Click Chemistry and Applications (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Lawrence R. McGee is often cited by papers focused on Chemical Synthesis and Analysis (4 papers), Click Chemistry and Applications (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Lawrence R. McGee collaborates with scholars based in United States. Lawrence R. McGee's co-authors include David A. Evans, Javier Bartrolí, James M. Takacs, Michael D. Ennis, David J. Mathre, Timothy D. Cushing, Daniela Metz, Douglas A. Whittington, Pat N. Confalone and Yuk‐Ching Tse‐Dinh and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Molecular Biology and Applied and Environmental Microbiology.

In The Last Decade

Lawrence R. McGee

28 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lawrence R. McGee United States 19 742 613 124 110 101 28 1.3k
John W. Ellingboe United States 25 906 1.2× 893 1.5× 113 0.9× 122 1.1× 74 0.7× 54 1.8k
Mark E. Schnute United States 19 715 1.0× 618 1.0× 81 0.7× 134 1.2× 72 0.7× 25 1.4k
Randall W. Hungate United States 22 748 1.0× 643 1.0× 109 0.9× 141 1.3× 120 1.2× 51 1.4k
Elizabeth A. Lunney United States 25 583 0.8× 1.0k 1.7× 118 1.0× 217 2.0× 73 0.7× 59 1.8k
Charles L. Cywin United States 16 573 0.8× 506 0.8× 67 0.5× 160 1.5× 71 0.7× 26 1.1k
Steven E. Hall United States 20 574 0.8× 952 1.6× 139 1.1× 126 1.1× 69 0.7× 40 1.5k
Atli Thorarensen United States 24 1.2k 1.7× 749 1.2× 123 1.0× 156 1.4× 34 0.3× 45 2.0k
Harold R. Almond United States 18 472 0.6× 590 1.0× 150 1.2× 68 0.6× 47 0.5× 32 1.2k
George S. Sheppard United States 22 769 1.0× 755 1.2× 141 1.1× 360 3.3× 149 1.5× 56 1.6k
Kenneth J. Barr United States 12 717 1.0× 693 1.1× 83 0.7× 117 1.1× 80 0.8× 17 1.4k

Countries citing papers authored by Lawrence R. McGee

Since Specialization
Citations

This map shows the geographic impact of Lawrence R. McGee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence R. McGee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence R. McGee more than expected).

Fields of papers citing papers by Lawrence R. McGee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence R. McGee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence R. McGee. The network helps show where Lawrence R. McGee may publish in the future.

Co-authorship network of co-authors of Lawrence R. McGee

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence R. McGee. A scholar is included among the top collaborators of Lawrence R. McGee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence R. McGee. Lawrence R. McGee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nguyen, Thomas T., Ulhas Bhatt, Kevin Li, et al.. (2023). Novel series of tunable µOR modulators with enhanced brain penetration for the treatment of opioid use disorder, pain and neuropsychiatric indications. Bioorganic & Medicinal Chemistry Letters. 92. 129405–129405. 1 indexed citations
2.
Rew, Yosup, Xiaohui Du, John Eksterowicz, et al.. (2018). Discovery of a Potent and Selective Steroidal Glucocorticoid Receptor Antagonist (ORIC-101). Journal of Medicinal Chemistry. 61(17). 7767–7784. 21 indexed citations
3.
Bui, Minna, Xiaolin Hao, Youngsook Shin, et al.. (2015). Synthesis and SAR study of potent and selective PI3Kδ inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(5). 1104–1109. 18 indexed citations
4.
Li, Cong, Liqin Liu, Lingming Liang, et al.. (2014). AMG 925 Is a Dual FLT3/CDK4 Inhibitor with the Potential to Overcome FLT3 Inhibitor Resistance in Acute Myeloid Leukemia. Molecular Cancer Therapeutics. 14(2). 375–383. 27 indexed citations
5.
Wang, Yingcai, Jieping Zhu, Jiwen Liu, et al.. (2014). Optimization beyond AMG 232: Discovery and SAR of sulfonamides on a piperidinone scaffold as potent inhibitors of the MDM2-p53 protein–protein interaction. Bioorganic & Medicinal Chemistry Letters. 24(16). 3782–3785. 13 indexed citations
6.
Li, Kexue, Lawrence R. McGee, Athena Sudom, et al.. (2013). Inhibiting NF-κB-inducing kinase (NIK): Discovery, structure-based design, synthesis, structure–activity relationship, and co-crystal structures. Bioorganic & Medicinal Chemistry Letters. 23(5). 1238–1244. 53 indexed citations
7.
Lucas, Brian S., Benjamin Fisher, Lawrence R. McGee, et al.. (2012). An Expeditious Synthesis of the MDM2–p53 Inhibitor AM-8553. Journal of the American Chemical Society. 134(30). 12855–12860. 32 indexed citations
8.
Du, Xiaohui, Darin J. Gustin, Xiaoqi Chen, et al.. (2009). Imidazo-pyrazine derivatives as potent CXCR3 antagonists. Bioorganic & Medicinal Chemistry Letters. 19(17). 5200–5204. 29 indexed citations
9.
Motani, Alykhan, Zhulun Wang, Jennifer Weiszmann, et al.. (2009). INT131: A Selective Modulator of PPARγ. Journal of Molecular Biology. 386(5). 1301–1311. 98 indexed citations
10.
Pattabiraman, Kanaka, et al.. (2009). Synthesis of novel biaryl 2-benzimidazoles and 2-benzothiazoles. Tetrahedron Letters. 50(14). 1571–1574. 6 indexed citations
11.
Kim, Choung U., Lawrence R. McGee, Steven H. Krawczyk, et al.. (1996). New Series of Potent, Orally Bioavailable, Non-Peptidic Cyclic Sulfones as HIV-1 Protease Inhibitors. Journal of Medicinal Chemistry. 39(18). 3431–3434. 56 indexed citations
12.
KRAWCZYK, S. H., et al.. (1996). Inhibition of HIV-1 RNase H Activity by Nucleotide Dimers and Monomers. Antiviral chemistry & chemotherapy. 7(1). 37–45. 8 indexed citations
13.
McDowell, Robert S., Brent Blackburn, Thomas R. Gadek, et al.. (1994). From Peptide to Non-Peptide. 2. The de Novo Design of Potent, Non-peptidal Inhibitors of Platelet Aggregation Based on a Benzodiazepinedione Scaffold. Journal of the American Chemical Society. 116(12). 5077–5083. 82 indexed citations
14.
Sariaslani, F. Sima, Lawrence R. McGee, Michael K. Trower, & Fulton G. Kitson. (1990). Lack of regio- and stereospecificity in oxidation of (+) camphor by Streptomyces griseus enriched in cytochrome P-450soy. Biochemical and Biophysical Research Communications. 170(2). 456–461. 17 indexed citations
15.
McGee, Lawrence R. & Pat N. Confalone. (1988). The photobiology of the gilvocarcins. Total synthesis of defucogilvocarcin V and a related photoactive vinyl phenol. The Journal of Organic Chemistry. 53(16). 3695–3701. 22 indexed citations
16.
Sariaslani, F. Sima, Lawrence R. McGee, & Derick W. Ovenall. (1987). Microbial transformation of precocene II: oxidative reactions by Streptomyces griseus. Applied and Environmental Microbiology. 53(8). 1780–1784. 26 indexed citations
17.
Evans, David A., James M. Takacs, Lawrence R. McGee, et al.. (1981). Chiral enolate design. Pure and Applied Chemistry. 53(6). 1109–1127. 206 indexed citations
18.
Evans, David A. & Lawrence R. McGee. (1981). ChemInform Abstract: ENANTIOSELECTIVE ALDOL CONDENSATIONS. 3. ERYTHRO‐SELECTIVE CONDENSATIONS VIA ZIRCONIUM ENOLATES. Chemischer Informationsdienst. 12(35). 11 indexed citations
19.
Evans, David A. & Lawrence R. McGee. (1980). Aldol diastereoselection zirconium enolates. Product-selective, enolate structure independent condensations.. Tetrahedron Letters. 21(41). 3975–3978. 106 indexed citations
20.
Epstein, William W., et al.. (1976). Mass spectral data for gas chromatograph-mass spectral identification of some irregular monoterpenes. Journal of Chemical & Engineering Data. 21(4). 500–502. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John W. Ellingboe Breakdown of academic impact, for papers by Mark E. Schnute Breakdown of academic impact, for papers by Randall W. Hungate Breakdown of academic impact, for papers by Elizabeth A. Lunney Breakdown of academic impact, for papers by Charles L. Cywin Breakdown of academic impact, for papers by Steven E. Hall Breakdown of academic impact, for papers by Atli Thorarensen Breakdown of academic impact, for papers by Harold R. Almond Breakdown of academic impact, for papers by George S. Sheppard Breakdown of academic impact, for papers by Kenneth J. Barr
Rankless by CCL
2026